Two dividend + growth stocks I’d buy with £2,000 today

Roland Head profiles two stocks buy-and-forget stocks that could help you build a retirement fund.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at two stocks which I believe could offer a rewarding mix of income and growth for new investors. Both stocks look reasonably priced to me, with good growth prospects.

A stronger position

Many industrial firms depend on specialist manufacturers to produce the components they need. Materials engineering specialist Morgan Advanced Materials (LSE: MGAM) is one of these firms, producing high-specification ceramic and electrical parts for use in markets including healthcare, electronics and oil and gas.

The group has been through a series of changes over the last few years, but today’s full-year results confirm that this process is complete and that the company is returning to growth.

Sales rose by 3.3% to £1,021.5m last year, while headline operating profit was 2.4% higher, at £119.7m. These figures give a respectable headline operating margin of 11.7%, broadly unchanged from 11.8% in 2016.

A return to growth?

Income investors may be slightly disappointed that the dividend has been held flat, at 11p per share. A flat dividend sometimes suggests that the payout is becoming unaffordable, but I don’t think that’s the case here.

Last year’s headline earnings of 22.5p covered the 11p per share payout dividend twice. The dividend was also covered by the group’s underlying free cash flow of £54m. I suspect that the board’s priority was to direct surplus cash towards debt reduction before raising the dividend.

The group’s net debt fell by 25% to £181.3m last year. This reduced the group’s borrowing multiple to 1.2 times earnings before interest, tax, depreciation and amortisation (EBITDA) — a fairly comfortable level.

Looking ahead, Morgan Advanced Materials looks well positioned for a return to growth. Adjusted earnings are expected to rise by 12% to 24.2p per share this year and a dividend hike of 2% has been pencilled in by analysts.

These forecasts put the stock on a 2018 P/E of 14, with a prospective yield of 3.4%. In my view, this could be a decent entry point for a long-term position.

One stock I’d hold forever

Morgan Advanced Materials could be vulnerable to cyclical downturns in major industries. I believe my next stock, Smiths Group (LSE: SMIN), may have a more defensive business.

This conglomerate owns a number of companies, but its two biggest divisions are Smiths Medical and Smiths Detection, both of which operate in fairly defensive markets.

Smiths Medical makes a wide range of devices, 82% of which are consumable and disposable, so generate a high level of repeat orders. Smiths Detection makes equipment such as airport security scanners. I expect demand for such equipment  to continue rising and this business also generates a high level of after-market support work.

These two divisions generated 50% of group revenue and about 53% of headline operating profit last year, providing solid support for other parts of the business with greater cyclical exposure.

A stock to buy and hold

In my opinion, Smiths Group is a high quality business, with attractive long-term growth potential. The group generated a return on capital employed of 16% last year and an operating margin of 20%. Both of these figures are well above average.

Earnings are expected to grow by around 10% per year in 2018 and 2019. The shares currently trade on a forecast P/E of 16 with a prospective yield of 2.8%. I think this is a fair price for a good business and rate the stock as a buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Morgan Advanced Materials. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »